Tandem Diabetes Care recalled 19 t:slim X2 Insulin Pumps on July 3, 2025, due to an app defect. The defect affects devices when set to right-to-left languages, potentially causing incorrect therapy decisions. This may lead to hypoglycemia or hyperglycemia.
an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent hypoglycemia or hyperglycemia.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Tandem Diabetes Care, Inc. or your healthcare provider for instructions. Notification method: Letter
The recalled product is the t:slim X2 Insulin Pump with the Tandem t:slim mobile app. The devices were distributed internationally, specifically to Israel. The recall involves 19 units.
An app defect occurs when the phone is set to a right-to-left language. This defect can cause app-pump pairing issues and graphical defects, which may result in incorrect therapy decisions.
There have been no reported injuries or deaths associated with this recall. The potential risks include hypoglycemia or hyperglycemia due to incorrect insulin delivery.
Patients and healthcare providers should stop using the t:slim X2 Insulin Pump immediately. Contact Tandem Diabetes Care or your healthcare provider for further instructions.
For more information, patients can reach Tandem Diabetes Care at the contact details provided in recall notification letters. Additional details can be found at the FDA website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.